13F filer · CIK 1511901
Broadfin Capital, LLC
New York, NY · filing since Q2 2013 · last filing Feb 14, 2020
Reported value
$823.2M
$-2.4M vs prior
Positions
54
New / sold out
15 / 16
Added / reduced
12 / 19
Turnover
18.5%
buys $152.9M · sells $163.3M
Top-10 weight
55.1%
Biggest buys vs Q1 2017
| Change | Security | Shares change | Change % | Est. trade value |
|---|---|---|---|---|
| New | IOVANCE BIOTHERAPEUTICS INC | +2,276,359 | – | +$16.7M |
| New | AERIE PHARMACEUTICALS INC | +310,000 | – | +$16.3M |
| New | ALNYLAM PHARMACEUTICALS INC | +181,200 | – | +$14.5M |
| Added | LA JOLLA PHARMACEUTICAL CO | +475,000 | +60.7% | +$14.1M |
| New | GILEAD SCIENCES INCCALL | +180,000 | – | +$12.7M |
| Added | CORIUM INTL INC | +1,649,605 | +59.2% | +$12.3M |
| New | NOVADAQ TECHNOLOGIES INC | +1,000,000 | – | +$11.7M |
| Added | ARATANA THERAPEUTICS INC | +1,489,500 | +40.3% | +$10.8M |
| New | LA JOLLA PHARMACEUTICAL COCALL | +150,000 | – | +$4.5M |
| New | NUVASIVE INC | +55,900 | – | +$4.3M |
17 more rows. Subscribe for $29/month to see every row, download the data and use the API.
Biggest sells vs Q1 2017
| Change | Security | Shares change | Change % | Est. trade value |
|---|---|---|---|---|
| Reduced | HORIZON PHARMA PLC | -1,603,372 | -28.3% | $-19.0M |
| Sold out | LION BIOTECHNOLOGIES INC | -2,509,059 | -100.0% | $-18.7M |
| Sold out | ADVAXIS INC | -1,519,259 | -100.0% | $-12.4M |
| Sold out | MEDICINES CO | -215,077 | -100.0% | $-10.5M |
| Reduced | ANTARES PHARMA INC | -2,838,678 | -37.1% | $-9.1M |
| Sold out | DURECT CORP | -8,506,229 | -100.0% | $-8.9M |
| Sold out | SEASPINE HLDGS CORP | -1,099,807 | -100.0% | $-8.6M |
| Reduced | HERON THERAPEUTICS INC | -529,044 | -10.7% | $-7.3M |
| Reduced | ENDO INTL PLC | -636,815 | -33.8% | $-7.1M |
| Sold out | BARD C R INC | -27,300 | -100.0% | $-6.8M |
25 more rows. Subscribe for $29/month to see every row, download the data and use the API.
Estimated trade value = change in shares × this quarter's implied price. 13F filings show quarter-end positions, not individual trades.
Reported value by quarter
Holdings · Q2 2017
| # | Security | Shares | Value | Weight |
|---|---|---|---|---|
| 1 | SPDR SERIES TRUSTPUTS&P BIOTECH | 1,000,000 | $77.2M | 9.38% |
| 2 | HERON THERAPEUTICS INCCOM | 4,418,359 | $61.2M | 7.43% |
| 3 | RETROPHIN INCCOM | 2,862,178 | $55.5M | 6.74% |
| 4 | HORIZON PHARMA PLCSHS | 4,060,847 | $48.2M | 5.86% |
| 5 | AVADEL PHARMACEUTICALS PLCSPONSORED ADR | 4,133,464 | $45.6M | 5.54% |
| 6 | ARATANA THERAPEUTICS INCCOM | 5,184,942 | $37.5M | 4.55% |
| 7 | LA JOLLA PHARMACEUTICAL COCOM PAR $.0001 2 | 1,257,887 | $37.4M | 4.55% |
| 8 | CORIUM INTL INCCOM | 4,436,726 | $33.1M | 4.02% |
| 9 | IGNYTA INCCOM | 2,941,247 | $30.4M | 3.70% |
| 10 | ANGIODYNAMICS INCCOM | 1,683,252 | $27.3M | 3.31% |
44 more rows. Subscribe for $29/month to see every row, download the data and use the API.